Member Info for Seaking1

I’m buying a few more 50 tomorrow as I’m sure the vaccine will get the go ahead very soon.

I wonder if the governments commitment to bear the cost of any liability against covid vaccine is because they are trying to help push AstraZeneca over the line.

GSK also has an improving long-term future. As well as a higher yield than other dividend-paying UK shares, its passive income prospects could gather pace as its plans to split into two separate companies are realised.

This may increase its efficiency and strengthen its financial position relative to healthcare sector peers. In the shorter term, GSK’s defensive characteristics may mean that it has a solid income outlook relative to other FTSE 100 shares. Taken from the fool.

Starting an upward trend. Worth holding going by the last results .

Well the sp is going up in expectation of AstraZeneca/Jenner vaccine being approved by the uk regulators. Which I am fairly confident will be announced within the next fortnight. Remember Oxford biomedica have 35 million pounds order on this outcome. You will get your 10 quid kernowlad. :-) stay safe all and at least think of others around you and don’t be selfish.

No broker notes are not worth the paper they are written on.AstraZeneca will go back up,

Moodys put AstraZeneca down to negative. Take note of this. Broker notes mean nothing. AstraZeneca will go back up.

Yes I just noted that. Some good volume being bought. Undervalued I think.

Very well said sak50.

I bought at 84 am I worried not in the least even top companies shares go up and dow and a lot have big debits but also make a lot of money as well. I will be buying a few more tomorrow.
Always allow for the long game not just the quick quid.

Thames, thanks for that I will watch.:-).

It looks like a stratigic move to me as eidos main source of income comes from a license agreement with Alexion.

No it wasn’t.

Good move in my opinion.

Took the loss 300 quid. Still I’m pretty sure my investment here will be quite good in time.

Need this to drop to About 1250 for my entry point. Although I believe it’s an excellent company and I may miss out on the takeover I can see coming in the future .

Sp doing very good. Let’s hope it breaks though the ceiling. If the vaccine gets the go ahead s it surely must we won’t be seeing 800 again as Oxford will be getting the 35 million for the production from AstraZeneca. :-)

Completely agree with your comments Jatw. It’s the other drugs that they have been getting approved that will make the money and the vaccine will be approved whenever. Very undervalued now.

Fair enough we all have our views and believe them. What I can say is that the immediate (next five tears or more ) is not going to be good. We will all be paying more taxes etc. So the only thing I can say chaps is invest as wisely as you can, and not be a prat like myself who just took a 300 pound hit by taking a punt in a Micky mouse investment, not that it matters to much to me it’s just the thought that I did it. -:). Stay safe.

Yes it must be brilliant to be a director and award yourself shares. Bent in my view.